Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
15.84
-0.03 (-0.19%)
Feb 20, 2026, 1:24 PM EST - Market open
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $12.22 billion as of February 20, 2026. Its market cap has decreased by -19.67% in one year.
Market Cap
12.22B
Enterprise Value
12.01B
1-Year Change
-19.67%
Ranking
Category
Stock Price
$15.84
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $12.22B, an increase of 10,164.72%. That is a compound annual growth rate of 52.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 11.81B | -9.26% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Pharma | 14.62B |
| Ascendis Pharma | 13.71B |
| Ionis Pharmaceuticals | 13.17B |
| BioMarin Pharmaceutical | 11.52B |
| Exelixis | 11.45B |
| Madrigal Pharmaceuticals | 11.07B |
| Avidity Biosciences | 10.98B |
| Jazz Pharmaceuticals | 10.21B |